[{"id":"cbbbf12a-b717-4455-8e26-aba7b6d63ae9","acronym":"","url":"https://clinicaltrials.gov/study/NCT05306132","created_at":"2022-03-31T16:52:52.697Z","updated_at":"2024-07-02T16:35:54.072Z","phase":"Phase 1","brief_title":"Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of ASKC202","source_id_and_acronym":"NCT05306132","lead_sponsor":"Jiangsu Aosaikang Pharmaceutical Co., Ltd.","biomarkers":" MET","pipe":" | ","alterations":" MET amplification","tags":["MET"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MET amplification"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ASKC202"],"overall_status":"Recruiting","enrollment":" Enrollment 150","initiation":"Initiation: 08/08/2022","start_date":" 08/08/2022","primary_txt":" Primary completion: 05/01/2024","primary_completion_date":" 05/01/2024","study_txt":" Completion: 05/01/2025","study_completion_date":" 05/01/2025","last_update_posted":"2023-03-06"}]